IL109770A0 - Thermal infusion process for preparing controlled release solid dosage forms of medicaments for oral administration and controlled release solid dosage forms of medicaments prepared thereby - Google Patents

Thermal infusion process for preparing controlled release solid dosage forms of medicaments for oral administration and controlled release solid dosage forms of medicaments prepared thereby

Info

Publication number
IL109770A0
IL109770A0 IL10977094A IL10977094A IL109770A0 IL 109770 A0 IL109770 A0 IL 109770A0 IL 10977094 A IL10977094 A IL 10977094A IL 10977094 A IL10977094 A IL 10977094A IL 109770 A0 IL109770 A0 IL 109770A0
Authority
IL
Israel
Prior art keywords
dosage forms
controlled release
solid dosage
medicaments
release solid
Prior art date
Application number
IL10977094A
Other languages
English (en)
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939311188A external-priority patent/GB9311188D0/en
Priority claimed from GB939316252A external-priority patent/GB9316252D0/en
Priority claimed from GB939318920A external-priority patent/GB9318920D0/en
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of IL109770A0 publication Critical patent/IL109770A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL10977094A 1993-05-29 1994-05-25 Thermal infusion process for preparing controlled release solid dosage forms of medicaments for oral administration and controlled release solid dosage forms of medicaments prepared thereby IL109770A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB939311188A GB9311188D0 (en) 1993-05-29 1993-05-29 Process
GB939316252A GB9316252D0 (en) 1993-08-05 1993-08-05 Process
GB939318920A GB9318920D0 (en) 1993-09-11 1993-09-11 Process

Publications (1)

Publication Number Publication Date
IL109770A0 true IL109770A0 (en) 1994-11-28

Family

ID=27266706

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10977094A IL109770A0 (en) 1993-05-29 1994-05-25 Thermal infusion process for preparing controlled release solid dosage forms of medicaments for oral administration and controlled release solid dosage forms of medicaments prepared thereby

Country Status (13)

Country Link
EP (1) EP0701436B1 (fr)
JP (1) JPH08510752A (fr)
CN (1) CN1124452A (fr)
AP (1) AP9400645A0 (fr)
AT (1) ATE230981T1 (fr)
AU (1) AU684522B2 (fr)
CA (1) CA2164003A1 (fr)
DE (1) DE69432015T2 (fr)
ES (1) ES2189803T3 (fr)
IL (1) IL109770A0 (fr)
MA (1) MA23212A1 (fr)
NZ (1) NZ268172A (fr)
WO (1) WO1994027557A2 (fr)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9402203D0 (en) * 1994-02-04 1994-03-30 Smithkline Beecham Plc Pharmaceutical formulation
GB9407386D0 (en) 1994-04-14 1994-06-08 Smithkline Beecham Plc Pharmaceutical formulation
GB9416600D0 (en) * 1994-08-17 1994-10-12 Smithkline Beecham Plc Pharmaceutical formulation
CN1289084C (zh) * 1995-09-07 2006-12-13 史密丝克莱恩比彻姆有限公司 药物制剂
TWI225402B (en) 1996-03-13 2004-12-21 Biochemie Gmbh Auxiliary-free agglomerates
AT407701B (de) * 1996-08-12 2001-05-25 Biochemie Gmbh Zur direkttablettierung geeignete mischung, die als wesentliche komponenten amoxicillin-trihydrat und das kaliumsalz der clavulansäure enthält und verfahren zur herstellung dieser mischung
FR2753904B1 (fr) * 1996-10-01 1998-10-30 Gattefosse Ets Sa Composition pharmaceutique a liberation modifiee de principe actif, comportant une matrice, et procede de fabrication
IL119627A (en) * 1996-11-17 2002-03-10 Yissum Res Dev Co PHARMACEUTICAL PREPARATIONS FOR THE CONTROLLED-RELEASE OF AN ACTIVE AGENT COMPRISING AT LEAST ONE β-LACTAM ANTIBIOTIC AGENT
CN1194687C (zh) * 1997-02-14 2005-03-30 史密斯克莱恩比彻姆药物实验室 含有阿莫西林和克拉维酸盐的药物制剂
DE19705538C1 (de) * 1997-02-14 1998-08-27 Goedecke Ag Verfahren zur Trennung von Wirkstoffen in festen pharmazeutischen Zubereitungen
CA2302275C (fr) 1997-09-19 2009-12-08 Shire Laboratories, Inc. Granule de solution solide
EP1017372A4 (fr) * 1997-10-03 2006-05-24 Smithkline Beecham Corp Formes galeniques solides a liberation controlee au carbonate de lithium
TR199901584T1 (xx) * 1997-11-17 2000-01-21 Gist-Brocades B.V. Klavulanat ve bir veya daha fazla ek madde içeren granüller
CA2314893C (fr) * 1997-12-22 2005-09-13 Euro-Celtique, S.A. Combinaison d'agonistes et d'antagonistes d'opioides
CN1203846C (zh) 1998-03-19 2005-06-01 布里斯托尔-迈尔斯斯奎布公司 高溶解性药物的双相控释递送系统和方法
US7250176B1 (en) 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
OA11926A (en) * 1999-04-13 2006-04-12 Beecham Pharmacueticals Pte Lt Novel method of treatment
US6623758B2 (en) 2000-02-24 2003-09-23 Advancis Pharmaceutical Corp. Cephalosporin-metronidazole antibiotic composition
US6663890B2 (en) 2000-02-24 2003-12-16 Advancis Pharmaceutical Corp. Metronidazole antibiotic product, use and formulation thereof
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6663891B2 (en) 2000-02-24 2003-12-16 Advancis Pharmaceutical Corp. Erythromyacin antibiotic product, use and formulation thereof
US6667057B2 (en) 2000-02-24 2003-12-23 Advancis Pharmaceutical Corp. Levofloxacin antibiotic product, use and formulation thereof
US6667042B2 (en) 2000-02-24 2003-12-23 Advancis Pharmaceutical Corp. Fluroquinilone antibiotic product, use and formulation thereof
US6632453B2 (en) 2000-02-24 2003-10-14 Advancis Pharmaceutical Corp. Ciprofoxacin-metronidazole antibiotic composition
US6610328B2 (en) 2000-02-24 2003-08-26 Advancis Pharmaceutical Corp. Amoxicillin-clarithromycin antibiotic composition
JP2003523372A (ja) 2000-02-24 2003-08-05 アドバンシス ファーマシューティカル コーポレイション 抗生物質及び抗真菌剤組成物
US6565882B2 (en) 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6627222B2 (en) 2000-02-24 2003-09-30 Advancis Pharmaceutical Corp. Amoxicillin-dicloxacillin antibiotic composition
US6730320B2 (en) 2000-02-24 2004-05-04 Advancis Pharmaceutical Corp. Tetracycline antibiotic product, use and formulation thereof
US6669948B2 (en) 2000-02-24 2003-12-30 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6991807B2 (en) 2000-02-24 2006-01-31 Advancis Pharmaceutical, Corp. Antibiotic composition
US7025989B2 (en) 2000-02-24 2006-04-11 Advancis Pharmaceutical Corp. Multiple-delayed released antibiotic product, use and formulation thereof
CA2399856C (fr) * 2000-02-24 2009-01-27 Edward M. Rudnic Composition antibiotique dotee d'inhibiteurs
US7838032B2 (en) 2000-04-28 2010-11-23 Reckitt Benckiser Inc. Sustained release of guaifenesin
US6955821B2 (en) 2000-04-28 2005-10-18 Adams Laboratories, Inc. Sustained release formulations of guaifenesin and additional drug ingredients
US7985420B2 (en) 2000-04-28 2011-07-26 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
US8012504B2 (en) 2000-04-28 2011-09-06 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
WO2002030392A2 (fr) 2000-10-12 2002-04-18 Beecham Pharmaceuticals (Pte) Limited Nouvelle formulation
US6541014B2 (en) 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US7157095B2 (en) 2000-10-13 2007-01-02 Advancis Pharmaceutical Corporation Multiple-delayed release antifungal product, use and formulation thereof
US7105174B2 (en) 2000-10-13 2006-09-12 Advancis Pharmaceutical Corporation Multiple-delayed release anti-neoplastic product, use and formulation thereof
US7074417B2 (en) 2000-10-13 2006-07-11 Advancis Pharmaceutical Corporation Multiple-delayed release anti-viral product, use and formulation thereof
US20020197314A1 (en) 2001-02-23 2002-12-26 Rudnic Edward M. Anti-fungal composition
AT413015B (de) * 2001-04-12 2005-10-15 Sandoz Ag Tablette enthaltend das k-salz der 3-(2-hydroxyethyliden)-7-oxo-4-oxa-1- azabicyclo(3.2.0)heptan-2 carbonsäure in hydrophobisierter form
GB0209265D0 (en) * 2002-04-23 2002-06-05 Novartis Ag Organic compounds
NZ542176A (en) * 2003-03-04 2007-12-21 Nostrum Pharmaceuticals Inc Control release formulation containing a hydrophobic material as the sustained release agent
CA2535398C (fr) 2003-08-12 2013-11-12 Advancis Pharmaceuticals Corporation Antibiotique, utilisation et formulation associees
BRPI0417348A (pt) * 2003-12-04 2007-03-13 Pfizer Prod Inc processo de gelatinização por spray com utilização de uma extrusora para preparação de composições de droga cristalina multiparticulada contendo preferencialmente um poloxámero e um glicerìdeo
KR20060109481A (ko) * 2003-12-04 2006-10-20 화이자 프로덕츠 인코포레이티드 바람직하게는 폴록사머와 글리세라이드를 함유하는다미립자 아지트로마이신 조성물의 제조를 위해 압출기를사용하는 분무응결 방법
PE20060652A1 (es) * 2004-08-27 2006-08-11 Novartis Ag Composiciones farmaceuticas de liberacion inmediata que comprenden granulos de fusion
KR101214665B1 (ko) 2004-09-16 2012-12-21 아스텔라스세이야쿠 가부시키가이샤 트리아졸 유도체 또는 그의 염
WO2012006398A2 (fr) 2010-07-09 2012-01-12 Bhv Pharma, Inc. Système d'administration à libération immédiate/retardée en combinaison pour des médicaments à courte demi-vie comprenant de la rémogliflozine
GB201420306D0 (en) 2014-11-14 2014-12-31 Bio Images Drug Delivery Ltd Compositions
GB201420311D0 (en) 2014-11-14 2014-12-31 Bio Images Drug Delivery Ltd Pharmaceutical processing
CA3001337C (fr) 2015-10-09 2023-12-12 Reckitt Benckiser Llc Formulation pharmaceutique
MX2022000250A (es) 2019-07-05 2022-02-03 Glaxosmithkline Ip No 2 Ltd Streptomyces clavuligerus.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132753A (en) * 1965-02-12 1979-01-02 American Cyanamid Company Process for preparing oral sustained release granules
JPS56140915A (en) * 1980-04-07 1981-11-04 Yamanouchi Pharmaceut Co Ltd Pharmaceutical preparation for solid drug
US5169645A (en) * 1989-10-31 1992-12-08 Duquesne University Of The Holy Ghost Directly compressible granules having improved flow properties

Also Published As

Publication number Publication date
CA2164003A1 (fr) 1994-12-08
ATE230981T1 (de) 2003-02-15
AU7096294A (en) 1994-12-20
DE69432015T2 (de) 2003-11-06
EP0701436B1 (fr) 2003-01-15
WO1994027557A2 (fr) 1994-12-08
WO1994027557A3 (fr) 1995-03-16
NZ268172A (en) 1997-12-19
CN1124452A (zh) 1996-06-12
EP0701436A4 (fr) 1997-05-21
JPH08510752A (ja) 1996-11-12
AP9400645A0 (en) 1994-07-31
DE69432015D1 (de) 2003-02-20
MA23212A1 (fr) 1994-12-31
AU684522B2 (en) 1997-12-18
ES2189803T3 (es) 2003-07-16
EP0701436A1 (fr) 1996-03-20

Similar Documents

Publication Publication Date Title
IL109770A0 (en) Thermal infusion process for preparing controlled release solid dosage forms of medicaments for oral administration and controlled release solid dosage forms of medicaments prepared thereby
HUT70157A (en) Imidazolylalcenoic acids, pharmaceutical compositions containing them, and process for producing them, and use of them for preparing medicaments
ZA871620B (en) Formulation for preparing sustained release drugs for oral administration
IL115646A (en) Medicinal and/or nutritional microcapsules for oral administration process for their preparation and galenical system containing them
HUT59314A (en) Process for producing pharmaceutical composition comprising minocylcine active ingredient and suitable for a single daily administration
IL92343A0 (en) Granulate for multiparticulate controlled release oral compositions,their preparation and oral pharmaceutical compositions containing them
HRP920229A2 (en) Release of medicinal substances and preparation process therefor
HUP9903734A3 (en) Controlled-release pharmaceutical formulations for oral administration and method for preparing this
AU2964692A (en) Method and apparatus for preprogrammed infusion of iv medicaments
ZA849373B (en) Method and composition for the preparation of controlled longacting pharmaceuticals for oral administration
PT77503A (en) Process for preparing pharmaceutical compositions for oral and/or enteral administration
EP0729748A4 (fr) Procede pour produire une composition de medicament stable, et preparation pharmaceutique
IL191582A (en) Process for preparing a pharmaceutical composition containing Ritonbir and use of Britonbir crystalline form ii for the preparation of a drug
NZ229518A (en) Pharmaceutical dosage form for the medication of fish: method of administration and (prophylactic) treatment
EP0582169A3 (en) Pharmaceutical preparations for the oral administration of dihydropyridines in beverage form
AU2782592A (en) Thermal enhancement of transdermal drug administration
HUT59319A (en) Pharmaceutical compositions with controlled release of active ingredient and process for producing same
ZA87216B (en) A pharmaceutical composition with sustained release of the active component and a process for the preparation thereof
AU3721293A (en) Pharmaceutical preparation for sustained release of a drug and process for producing the same
AR244243A1 (es) Procedimiento para preparar timolinfotropina.
HUP9801947A3 (en) Device and process for mixing a pharmaceutical composition with another agent and method for oral administration of the pharmaceutical preparation
GB8901833D0 (en) Pharmaceutical formulations with controlled drug release
IL116615A0 (en) A transdermal therapeutic system for the administration of (s)-3-methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazole and of salts thereof
ZA943736B (en) A thermal infusion process for preparing controlled release solid dosage forms of medicaments
ZA961314B (en) Substituted benzenesulfonylureas and -thioreas processes for their preparation their use for the production of pharmaceutical preparations and medicaments containing them